CoChat

Clinical outcomes of hospitalised patients with COVID-19 and chronic inflammatory and autoimmune rheumatic diseases: a multicentric matched cohort study

Open access
Pablos, Jose L, Galindo, María, Carmona, Loreto, Lledó, Ana, Retuerto, Miriam, Blanco, Ricardo, Gonzalez-Gay, Miguel A, Martinez-Lopez, David, Castrejón, Isabel, Alvaro-Gracia, José M, Fernández Fernández, David, Mera-Varela, Antonio, Manrique-Arija, Sara, Mena Vázquez, Natalia, Fernandez-Nebro, Antonio · 2020 · Annals of the Rheumatic Diseases

Published version of a preprint

The DOI matches its Crossref record; 32 of the 35 references it cites were found in a registry or an index.

Abstract

Objectives The impact of inflammatory rheumatic diseases on COVID-19 severity is poorly known. Here, we compare the outcomes of a cohort of patients with rheumatic diseases with a matched control cohort to identify potential risk factors for severe illness.Methods In this comparative cohort study, we identified hospital PCR+COVID-19 rheumatic patients with chronic inflammatory arthritis (IA) or connective tissue diseases (CTDs). Non-rheumatic controls were randomly sampled 1:1 and matched by age, sex and PCR date. The main outcome was severe COVID-19, defined as death, invasive ventilation, intensive care unit admission or serious complications. We assessed the association between the outcome and the potential prognostic variables, adjusted by COVID-19 treatment, using logistic regression.Results The cohorts were composed of 456 rheumatic and non-rheumatic patients, in equal numbers. Mean age was 63 (IQR 53-78) years and male sex 41% in both cohorts. Rheumatic diseases were IA (60%) and CTD (40%). Most patients (74%) had been hospitalised, and the risk of severe COVID-19 was 31.6% in the rheumatic and 28.1% in the non-rheumatic cohort. Ageing, male sex and previous comorbidity (obesity, diabetes, hypertension, cardiovascular or lung disease) increased the risk in the rheumatic cohort by bivariate analysis. In logistic regression analysis, independent factors associated with severe COVID-19 were increased age (OR 4.83; 95% CI 2.78 to 8.36), male sex (1.93; CI 1.21 to 3.07) and having a CTD (OR 1.82; CI 1.00 to 3.30).Conclusion In hospitalised patients with chronic inflammatory rheumatic diseases, having a CTD but not IA nor previous immunosuppressive therapies was associated with severe COVID-19.

Overview

Integrity signals

Registry

Crossref · 10.1136/annrheumdis-2020-218296

Cites

32 of 32 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

2 retracted

Show all 32 references

Cited by

See all 241

Metadata

Authors
Pablos, J. L., Galindo, M., Carmona, L., Lledó, A., Retuerto, M., Blanco, R., Gonzalez-Gay, M. A., Martinez-Lopez, D., Castrejón, I., Alvaro-Gracia, J. M., Fernández Fernández, D., Mera-Varela, A., Manrique-Arija, S., Mena Vázquez, N., & Fernandez-Nebro, A.
Affiliations
  • Instituto de Salud Musculoesquelética (ES)
  • Universidad Complutense de Madrid (ES)
  • Marqués de Valdecilla University Hospital (ES)
  • Hospital General Universitario Gregorio Marañón (ES)
Venue
Annals of the Rheumatic Diseases
Publisher
Elsevier BV
Published
2020-12
Volume
79
Issue
12
Pages
1544-1549
ISSN
0003-4967 (ISSN-L)
OpenAlex
W3048431881
Cited by
238
References
35
Citations by year
2026: 4 · 2025: 4 · 2024: 20 · 2023: 51 · 2022: 55 · 2021: 81 · 2020: 23
FWCI
6.89
Type
journal article
Language
en
Open access
Licence
  • www.elsevier.com/tdm/userlicense/1.0/ (tdm)
  • www.elsevier.com/legal/tdmrep-license (tdm)
Locations
  • Annals of the Rheumatic Diseases (publishedVersion)
  • medRxiv (acceptedVersion)
  • PubMed (publishedVersion)
  • RISalud Institutional Health Repository of Andalucía (submittedVersion, other-oa)
  • HighWire Press Open Archive (submittedVersion)
Funders
  • European Regional Development Fund (N/A)
  • Fondo de Investigación Sanitaria, Instituto de Salud Carlos III (RD16/0012 RETICS program)
Topics
  • Health Sciences › Medicine › Infectious Diseases › COVID-19 Clinical Research Studies
  • Health Sciences › Medicine › Rheumatology › Rheumatoid Arthritis Research and Therapies
  • Health Sciences › Medicine › Rheumatology › Systemic Sclerosis and Related Diseases
Keywords
COVID-19 pandemic, chronic inflammatory rheumatic diseases, connective tissue diseases, inflammatory arthritis, disease severity, hospitalized patients, risk factors, comorbidities, age, sex, immunosuppressive therapy, mortality, intensive care unit admission
MeSH terms
Betacoronavirus, COVID-19, SARS-CoV-2, COVID-19 Drug Treatment, Adenosine Monophosphate, Age Factors, Aged, Alanine, Antiviral Agents, Arthritis, Rheumatoid, Cardiovascular Diseases, Connective Tissue Diseases, Drug Combinations, Female, Glucocorticoids, Hospitalization, Humans, Hydroxychloroquine, Immunosuppressive Agents, Lupus Erythematosus, Systemic, Male, Middle Aged, Obesity, Pneumonia, Viral, Polymyalgia Rheumatica, Prognosis, Rheumatic Diseases, Risk Factors, Severity of Illness Index, Sex Factors, Sjogren's Syndrome, Cohort Studies, Arthritis, Psoriatic, Comorbidity, Logistic Models, Case-Control Studies, Coronavirus Infections, Ritonavir, Spondylarthropathies, Pandemics, Lopinavir

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Clinical outcomes of hospitalised patients with COVID-19 and chronic inflammatory and autoimmune rheumatic diseases: a multicentric matched cohort study. https://app.cochat.ai/papers/10.1136/annrheumdis-2020-218296
The paper
Pablos, J. L., Galindo, M., Carmona, L., Lledó, A., Retuerto, M., Blanco, R., Gonzalez-Gay, M. A., Martinez-Lopez, D., Castrejón, I., Alvaro-Gracia, J. M., Fernández Fernández, D., Mera-Varela, A., Manrique-Arija, S., Mena Vázquez, N., & Fernandez-Nebro, A. (2020). Clinical outcomes of hospitalised patients with COVID-19 and chronic inflammatory and autoimmune rheumatic diseases: a multicentric matched cohort study. Annals of the Rheumatic Diseases. https://doi.org/10.1136/annrheumdis-2020-218296

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.